![]() |
|
|
Vol. 54, Issue 3, 577-583, September 1998
Pharma Division, Preclinical Research, F. Hoffmann-La Roche, Ltd.,
4070 Basel, Switzerland
Ro 63-0563 [4-amino-N-(2,6
bis-methylamino-pyridin-4-yl)-benzene sulfonamide] is a high affinity
5-hydroxytryptamine6 (HT6) receptor antagonist
with more than 100-fold selectivity for the 5-HT6 receptor
compared with 69 other receptors and binding sites. The present study
describes the properties of [3H]Ro 63-0563, the first
selective 5-HT6 receptor radioligand. Specific binding of
[3H]Ro 63-0563 (nonspecific binding defined in the
presence of 10 µM methiothepin) to recombinant rat and
human 5-HT6 receptors was saturable, rapid, and reversible
with equilibrium dissociation constants
(Kd) of 6.8 nM
and 4.96 nM, respectively. The pharmacological profile
of the rat 5-HT6 receptor labeled with [3H]Ro
63-0563 (methiothepin > D-lysergic acid
diethylamide > clozapine ~ Ro 63-0563 > lisuride > ergotamine ~ Ro 04-6790 > 5-HT > amitriptyline ~ metergoline ~ mianserin ~ ritanserin > methysergide > mesulergine) was similar to
that obtained by using either
[3H]D-lysergic acide diethylamide or
[3H]5-HT as radioligand. In equilibrium binding studies
with rat striatal membranes, [3H]Ro 63-0563 labeled a
single binding site with Kd and Bmax values of 11.7 nM and
175 fmol/mg protein, respectively. In porcine striatal membranes,
[3H]Ro 63-0563 also labeled a single binding site with
Kd and
Bmax values of 8.0 nM and
130 fmol/mg protein, respectively. The affinities of 14 5-HT6 receptor ligands at this binding site were similar to
those found for the recombinant rat and human 5-HT6
receptor, which suggested the presence of 5-HT6 receptors in porcine striatum.
This article has been cited by other articles:
![]() |
K. E. Scrogin, A. K. Johnson, and V. L. Brooks Methysergide delays the decompensatory responses to severe hemorrhage by activating 5-HT1A receptors Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2000; 279(5): R1776 - R1786. [Abstract] [Full Text] [PDF] |
||||